1Robert W,Memurray MD,Kenneth J,et al. Cox-2 inhibitors: today and tomorrow[J].Am J Med Sci,2002;323(4) :181-189.
2Sharpe CR, Collet JP, McNutt M, et al. Nested casecontrol study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage[J]. Br J Cancer, 2000;83(1):112-120.
3Harris RE, Alshafie GA, Abou-Issa H, et al. Chemoprevention of breast cancer in rats by celecoxlib, a eyclooxygenase 2 inhibitor[J]. Cancer Res, 2000 ; 60(8) : 2101 - 2103.
4Nakatsugi S, Ohta T, Kawamori T, et al. Chemoprevention by nimesulide, a selective cyclooxygenase 2 inhibitor, of 2-amino-lmethy-6-phenylimidazo[4,5 b]pyridine(PhIP) -induced mammary gland carcinogenesis in rats[J]. Jpn J Cancer Res,2000;91(9) :886-892.
5Tsujii M, Kawano S, DuBois RN. Cyclooxygenases-2 expression in human colon cancer cells increases metastatic potential[J]. Proc Natl Acad Sic USA, 1997, 94 (7):3336-40.
6Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors[J]. Cancer, 2000, 89 (12) :2637-45.
7Ristimaki A, Nieminen O, Saukkonen K, et al. Expression of cyclooxygenase-2 in human transitional cell carconima of the urinary bladder[J]. Am J Pathol, 2001,158 (3) :849-53.
8Fujiwaki R, Iida K, Kanasaki H, et al. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth faotor and thymidine phosphorylase[J]. Hum Pathol, 2002,33 (2) : 213-9.
9Costa C, Soares R, Reis-Filho JS, et al. Clyclooxygenase-2 expession is associated with angiogenesis and lymph node metastasis in human breast cancer[J]. J Clin Pathol, 2002,55 (6) :429-34.
10Tavassoli FA, Devilee P. World Health Organization classification of tumors. Pathology and genetics, tumors of the breast and female genital organs[M]. Lyon: IARC Press,2003:63-73.
10Naito S, von Eschenbach A C, Giavazzi R, et al. Growth and me-tastasis of tumor cells isolated from a human renal cell carcinomaimplanted into different organs of nude mice [ J] . Cancer Res,1986,46(8) : 4109-15.
